Skip to main content

Table 3 Univariable and multivariable model of association with a detectable viral load

From: The association between a detectable HIV viral load and non-communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, South Africa

Variables N of each variable. N = 298. (% that had a detectable viral load) Univariable logistic regression:
Odds ratio (Confidence Interval)
Likelihood Ratio Test P value for univariable model Multivariable Odds ratio (Confidence Interval) Likelihood Ratio Test P value for multivariable model
Age      0.02
 25–34 75 (25) 1.00 0.08 1.00  
  ≥ 35 223 (16) 0.57 (0.30–1.07)   0.40 (0.19–0.84)  
Sex
 Male 76 (22) 1.00 0.32 1.00 0.02
 Female 222 (17) 0.72 (0.38–1.36)   3.26 (1.17–9.04)  
Smoking
 Never smoked 228 (14) 1.00 < 0.001 1.00 < 0.001
 Ever smoked 70 (34) 3.32 (1,78–6.18)   3.95 (1.53–10.18)  
BMI
 Obese 109 (12) 1.00 0.01 1.00 0.06
 Overweight 82 (15) 1.27 (0.54–2.94)   1.15 (0.45–2.90)  
 Normal/Underweight 107 (28) 2.88 (1.40–5.89)   2.57 (1.08–6.13)  
CD4
 Low: 0–299 73 (41) 1.00 < 0.001 1.00 < 0.001
 300–449 58 (19) 0.34 (0.15–0.75)   0.28 (0.12–0.67)  
 450–599 79 (9) 0.14 (0.06–0.34)   0.12 (0.05–0.33)  
 High: ≥600 88 (8) 0.12 (0.05–0.31)   0.12 (0.05–0.32)  
Presence of any comorbidity (indicator iv)      0.15
 No 168 (18) 1.00 0.76 1.00  
 Yes 130 (19) 1.09 (0.61–1.97)   1.64 (0.84–3.23)  
Duration of ART
 0.5–2.5 81 (20) 1.00 0.24
 2.6–4.0 73 (15) 0.72 (0.31–1.67)    
 4.1–6.0 55 (27) 1.52 (0.68–3.41)    
  > 6.0 89 (15) 0.70 (0.31–1.55)    
Previous diagnosis of comorbidity from clinic folders (indicator i)
 No 256 (18) 1.00 0.92
 Yes 42 (20) 1.05 (0.46–2.41)    
Previous diagnosis of comorbidity from interview (indicator ii)
 No 244 (19) 1.00 0.44
 Yes 54 (15) 0.73 (0.32–1.65)    
Previous diagnosis of comorbidity from either clinic folder or interview (indicator iii)
 No 240 (19) 1.00 0.51
 Yes 58 (15) 0.77 (0.36–1.69)    
Diagnosis of hypertension on the day (N = 288)
 Not Hypertensive 186 (17) 1.00 0.49
 Hypertensive 102 (21) 1.25 (0.68–2.30)    
Number of comorbidities
 0 240 (19) 1.00 0.45   
 1 44 (16) 0.79 (0.33–1.90)    
  ≥ 2 14 (14) 0.70 (0.15 3.24)    
  1. Significant results in italics